Macquarie Initiates Coverage On BeiGene with Outperform Rating, Announces Price Target of $259
Portfolio Pulse from Benzinga Newsdesk
Macquarie analyst Jake Lynch has initiated coverage on BeiGene (NASDAQ:BGNE) with an Outperform rating and a price target of $259.
September 12, 2023 | 1:25 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Macquarie has initiated coverage on BeiGene with an Outperform rating and a price target of $259, which could positively impact the stock's performance.
Analyst ratings and price targets can significantly influence a stock's performance. In this case, Macquarie's Outperform rating and high price target for BeiGene suggest a positive outlook for the stock, which could attract investors and drive up the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100